GHK-Cu is one of the most extensively studied regenerative peptides on the planet, backed by over 40 years of peer-reviewed research and thousands of published studies
February 2027 Review Schedule for GHK-Cu, Melanotan II, and Others The remaining peptides, including GHK-Cu and Melanotan II, are scheduled for the February 2027 PCAC review
DOI: 10.1016/S0140-6736(21)00845-X Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, et al
Dosis Inyectables Rango estndar: 1-5 mg por va subcutnea de 3 a 7 veces por semana, aunque muchos protocolos favorecen las dosis ms bajas de 1-2 mg diarios
So Where Does GHK-Cu Stand
We ship lyophilized peptides at ambient temperature in protective packaging